Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Apr 1, 2010
Distillery Therapeutics
Indication: Infectious disease
...preclinical testing in a mouse model of nematode infection. Tribendimidine is marketed in China by
Shandong Xinhua Pharmaceutical Co. Ltd.
...
Read More
BioCentury
|
Sep 27, 1999
Company News
Medisys plc, Shandong Xinhua Medical Instrument Co. sales and marketing update
...glucose monitoring kit. Shandong paid £150,000 ($244,000) for the license. Medisys plc (LSE:MDY), Ipswich, U.K.
Shandong Xinhua
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Apr 1, 2010
Distillery Therapeutics
Indication: Infectious disease
...preclinical testing in a mouse model of nematode infection. Tribendimidine is marketed in China by
Shandong Xinhua Pharmaceutical Co. Ltd.
...
Read More
BioCentury
|
Sep 27, 1999
Company News
Medisys plc, Shandong Xinhua Medical Instrument Co. sales and marketing update
...glucose monitoring kit. Shandong paid £150,000 ($244,000) for the license. Medisys plc (LSE:MDY), Ipswich, U.K.
Shandong Xinhua
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page